Brenig has launched an early Phase 1 trial to evaluate BT-409, its experimental small molecule therapy, in healthy volunteers ...

An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...

Funding to address one of drug discovery’s most critical bottlenecks by developing small-molecule drugs for historically ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

The agreement includes an upfront payment, with potential future payments linked to development, regulatory, and commercial ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

Opportunities in RNA Targeting Small Molecule Drug Discovery are driven by advances in RNA biology, structural analysis, and ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Developing targeted small molecule quantitative workflows for clinical research presents many challenges to researchers. From determining the optimum methods needed to enhance selectivity and ...

Funding will accelerate development of first-in-class small-molecule drugs for a condition with no approved targeted ...

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...